Skip to main content

Omthera Pharmaceuticals Inc (NASDAQ:OMTH) Investor Investigation Concerning Potential Breaches Of Fiduciary Duties In Takeover

  • If you purchased shares of Omthera Pharmaceuticals Inc (NASDAQ:OMTH) prior to May 28, 2013, and currently hold any of those NASDAQ:OMTH shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

May 29, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Omthera Pharmaceuticals Inc (NASDAQ:OMTH) shares was announced concerning whether the offer by AstraZeneca to acquire Omthera Pharmaceuticals Inc for $12.70 per NASDAQ:OMTH share and the takeover process are unfair to investors in NASDAQ:OMTH shares. The investigation by a law firm concerns whether cer...



You must register (for free) or login to view the entire investigation.